| Date | Form | Description | Docs | XBRL | Pages |
| 11/27/96 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
11 | |
| 09/13/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 06/24/96 | DEF 14A | Definitive proxy statements |
|
14 | |
| 06/19/96 | 10-C | Change of number of shares outstanding or change of issuer name |
|
2 | |
| 06/18/96 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
1 | |
| 06/18/96 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 | |
| 06/14/96 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 06/13/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 04/24/96 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 04/22/96 | 8-K | Current report filing |
|
4 |
Latest News & Events
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
Read More...